How AI Is Transforming Detection of Congenital Heart Defects
In prenatal cardiology, that clarity can mean earlier diagnoses, safer deliveries, and better supported families who are prepared for what lies ahead.
In prenatal cardiology, that clarity can mean earlier diagnoses, safer deliveries, and better supported families who are prepared for what lies ahead.
New advancements can only be fully realized when clinicians, lawmakers, and patients come together. Biomarker tests not only have the potential to improve patient outcomes and address health equity, they can also decrease expenses for financially vulnerable medical systems.
Natera, a diagnostics company most known for its prenatal testing segment, just raised $55.5 million to expand its salesforce and marketing reach, and invest in R&D that pivots toward the field of precision medicine. The dollars will go toward expanding its global sales and marketing force, as well as expanding its R&D for existing tests and […]